Top compounds associated with response to CCL20


Feature Type Standardized
Nominal ANOVA
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.067 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.03
mRNA UNC0638 GDSC1000 pan-cancer AAC -0.064 0.03
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA BHG712 GDSC1000 pan-cancer AAC -0.062 0.04
mRNA tamatinib CTRPv2 pan-cancer AAC -0.076 0.04
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC -0.096 0.04
mRNA Bleomycin CTRPv2 pan-cancer AAC 0.076 0.04
mRNA GW 441756 GDSC1000 pan-cancer AAC 0.073 0.04
Download CSV